By Sarah Mirando  |  April 11, 2013

Category: Pharmaceuticals
{loadposition pradaxa_lawsuit}
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

New Pradaxa Side Effects Examined Regarding Viral Infections

By John Curran

 

Pradaxa side effectsMany people are learning that the blood thinner Pradaxa has been linked to cerebral hemorrhage side effects, but researchers have found that the drug’s method of action may also impact immune system function.

In Chapel Hill, scientists found that the immune system’s defense against viral infections involves a protein enzyme called thrombin. While Pradaxa internal bleeding side effects are caused by inhibiting coagulation, it does so by limiting this enzyme. Unfortunately, the University of North Carolina researchers found that it also inhibits the body’s response to viral infections.

It is only the first study, but it could indicate further problems with Pradaxa beyond cerebral hemorrhage side effects. While bleeding in the brain or abdominal cavity can lead to sudden death, so too can the viral infection myocarditis. It is another potential fatal consequence of the blood thinner. A lack of immune system response in older patients at risk for clotting or a stroke may also cause problems during the flu season.

While this represents a new concern, patients should recognize that Pradaxa internal bleeding side effects have killed hundreds of people each year. That does not tell the whole story, however. In spite of FDA statements that the drug is safer than the generic warfarin, also known as Coumadin, there is no antidote for Pradaxa bleeding, unlike bleeding that occurs with warfarin. Instead, emergency room doctors rush to pump out the blood from affected areas.

In spite of all this, a pharmacist in New Jersey says that Pradaxa may be one of the most popular blood thinners in the United States, with perhaps hundreds of thousands of people who take it in any given year. While these medications are occasionally used after injuries for a brief period, many are considered maintenance treatments for older patients, note Pradaxa lawsuit attorneys. This increases the risks for both viral infections and hemorrhaging issues.

Since the FDA does not acknowledge the lack of an antidote for bleeding problems in its documentation, many users may not be aware of the risks. There are legal options if one has been hurt or worse as a result of the medication. Learn more at the Pradaxa Internal Bleeding Class Action Lawsuit Investigation. While there, get a free consultation with a Pradaxa lawsuit attorney by filling out the short form there. It costs nothing but is the first step in establishing one’s eligibility to file a claim against the drug’s maker.

 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated April 11th, 2013

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.